Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever
Background DNA-launched vaccine is “manufactured” in vaccinated individuals and does not require traditional vaccine manufacturing facility and technology. Goals. Using yellow fever 17D vaccine, we have provided proof-of-concept evidence that these vaccine can be launched from DNA and induce specifi...
Saved in:
Main Authors: | P. Pushko, А. А. Ishmukhametov, P. P. Bredenbeek, I. S. Lukashevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2019-03-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/657 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of electroporation to deliver DNA-based vaccines
by: Denis N Kisakov, et al.
Published: (2024-12-01) -
Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01) -
Advanced Laboratory Methods for Detecting Yellow Fever Pathogen
by: E. I. Krivosheina, et al.
Published: (2021-07-01) -
A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers
by: Shinji Fukushima, et al.
Published: (2025-06-01) -
Commerce, conflict, and contamination: yellow fever in early-independence Veracruz in the US imaginary, 1821-1848
by: Beau D.J. Gaitors